Australia has launched its first-ever clinical trial for cannabis, a focus of which will be the effects that a CBD oil-based treatment has on post-traumatic stress disorder (PTSD) in servicemen and women.
Running over 12 months, the trial will specifically target defence personnel who have not found success in treating their symptoms with pharmaceutical treatments. The trial, which is a collaborative effort among Cannabis Access Clinics, BOD Australia and Applied Cannabis Research, is approved by the Therapeutic Goods Administration, part of the Australian government.
Lead researcher Dr. Sharron Davis reports that traditional treatments have proved ineffective at addressing PTSD. Since the disorder can present with a variety of symptoms, it can be difficult to identify a treatment that is effective for all. Davis reported that participants in the trial have tried conventional